Volume :
5
Issue :
3
Abstract :
Diabetes Mellitus is a serious problem universally, by and large in both developing as well as underdeveloped nations. Conversely, a synthetic drug management of diabetes mellitus creates an unexpected adverse effect towards all organs and it is not safeguarding too. However, numerous enzymes, which is a real concern and may be accountable for diabetes mellitus and its associated complications, which would certainly afford a plenty of scope and platform to explore out the main target enzyme. These enzymes are to be targeted in treating diabetes mellitus may have a proven advantage in reducing the diabetes mellitus consequences. There are several evidences indicated Protein Tyrosine Phosphatase and variety of isomers are responsible diabetes mellitus, however Protein Tyrosine Phosphatase and its isomers are hardly targeted, due to inappropriate clinically validation lapse. Researchers are clinically validating the indeterminate Protein Tyrosine Phosphatase to establish an efficient method for variability of Protein Tyrosine Phosphatase enzyme levels of various clinical conditions of diabetes mellitus and its associated diseases.